{"id":2079,"date":"2025-01-27T18:41:09","date_gmt":"2025-01-27T15:41:09","guid":{"rendered":"https:\/\/systempharm.com.ua\/?p=2079"},"modified":"2025-02-13T15:08:09","modified_gmt":"2025-02-13T12:08:09","slug":"ceretilin-an-innovative-neuroprotector","status":"publish","type":"post","link":"https:\/\/systempharm.com.ua\/en\/ceretilin-an-innovative-neuroprotector\/","title":{"rendered":"CERETILIN: An Innovative Neuroprotector for Brain Protection and Recovery"},"content":{"rendered":"<p>System Pharm introduces Ceretilin, a cutting-edge pharmaceutical solution designed to support patients with neurological disorders. This advanced medication demonstrates potent neuroprotective properties, facilitates the regeneration of damaged brain tissue, and alleviates the severity of neurological symptoms.<\/p>\n<p>Key Benefits of Ceretilin<br \/>\nReduces the extent of brain tissue damage.<br \/>\nLowers neurological deficits.<br \/>\nAccelerates the recovery process after neurological injuries.<br \/>\nMinimizes the intensity of post-traumatic syndrome.<br \/>\nEnhances brain function and activity.<br \/>\nComposition<br \/>\nActive Ingredient: Citicoline.<br \/>\nEach 4 ml ampoule contains 500 mg or 1000 mg of citicoline.<br \/>\nExcipients: Concentrated hydrochloric acid, sodium hydroxide, water for injection.<\/p>\n<p>Indications<br \/>\nCeretilin is indicated for the treatment of:<\/p>\n<p>Acute phases of stroke, complications, and consequences of cerebrovascular accidents.<br \/>\nTraumatic brain injuries and their neurological outcomes.<br \/>\nCognitive impairments and behavioral disorders associated with chronic vascular and degenerative cerebral conditions.<br \/>\nContraindications<br \/>\nHypersensitivity to citicoline or any other component of the drug.<br \/>\nIncreased tone of the parasympathetic nervous system.<br \/>\nSpecial Administration Guidelines<br \/>\nFor intravenous use, administer slowly over 3\u20135 minutes, depending on the dose.<br \/>\nFor intravenous infusion, maintain a drip rate of 40\u201360 drops per minute.<br \/>\nIn cases of persistent intracranial hemorrhage, do not exceed a dose of 1000 mg\/day, with an infusion rate of no more than 30 drops per minute.<br \/>\nPrecautions:<\/p>\n<p>Ceretilin contains sodium, requiring caution for patients on a sodium-controlled diet.<br \/>\nDuring pregnancy or breastfeeding, use only if the potential therapeutic benefit outweighs the possible risk.<br \/>\nDosage and Administration<br \/>\nRecommended Dose for Adults: 500\u20132000 mg per day, depending on the patient\u2019s condition.<br \/>\nMethods of Administration: Intramuscularly or intravenously (slow injection or drip infusion).<br \/>\nDuration of Treatment: Determined individually by the physician.<br \/>\nElderly patients do not require dose adjustments.<br \/>\nThe injection solution is intended for single use only. Any remaining solution must be discarded.<br \/>\nDrug Interactions<br \/>\nCeretilin enhances the effect of levodopa.<br \/>\nAvoid simultaneous use with medications containing meclofenoxate.<\/p>\n<p>Why Choose Ceretilin?<br \/>\nCeretilin is more than just a medication \u2014 it\u2019s a comprehensive solution for brain protection and recovery. With scientifically proven efficacy and exceptional quality, it is a reliable choice for the treatment of complex neurological conditions.<\/p>\n<p>Ceretilin \u2014 Supporting the Brain, Restoring the Future!<\/p>","protected":false},"excerpt":{"rendered":"<p>System Pharm introduces Ceretilin, a cutting-edge pharmaceutical solution designed to support patients with neurological disorders. This advanced medication demonstrates potent neuroprotective properties, facilitates the regeneration of damaged brain tissue, and alleviates the severity of neurological symptoms. Key Benefits of Ceretilin Reduces the extent of brain tissue damage. Lowers neurological deficits. Accelerates the recovery process after [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":2081,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-2079","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-1"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/systempharm.com.ua\/en\/wp-json\/wp\/v2\/posts\/2079"}],"collection":[{"href":"https:\/\/systempharm.com.ua\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/systempharm.com.ua\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/systempharm.com.ua\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/systempharm.com.ua\/en\/wp-json\/wp\/v2\/comments?post=2079"}],"version-history":[{"count":1,"href":"https:\/\/systempharm.com.ua\/en\/wp-json\/wp\/v2\/posts\/2079\/revisions"}],"predecessor-version":[{"id":2082,"href":"https:\/\/systempharm.com.ua\/en\/wp-json\/wp\/v2\/posts\/2079\/revisions\/2082"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/systempharm.com.ua\/en\/wp-json\/wp\/v2\/media\/2081"}],"wp:attachment":[{"href":"https:\/\/systempharm.com.ua\/en\/wp-json\/wp\/v2\/media?parent=2079"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/systempharm.com.ua\/en\/wp-json\/wp\/v2\/categories?post=2079"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/systempharm.com.ua\/en\/wp-json\/wp\/v2\/tags?post=2079"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}